Hydroxychloroquine and COVID-19

Hydroxychloroquine and COVID-19 - هیدروکسی کلروکین و درمان کرونا

The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with pneumonia due to covid-19, finds a study from France published by The BMJ today. Adverse events were more common in those receiving the drug.

Release date: 15 May 2020

Source: BMJ